Preview

PDF, English Download (32MB) | Terms of use

Abstract

Iron plays a critical role as an oxygen carrier in hemoglobin as well as a constituent of iron-sulfur clusters. Increasing evidence suggests that mechanisms maintaining iron homeostasis cross-talk to intermediary metabolism. The liver hormone hepcidin is the key regulator of systemic iron metabolism. Hepcidin transcriptional control is linked to the nutrient-sensing mTOR pathway, proliferative signals, gluconeogenic responses during starvation and hormones that modulate energy metabolism. The aim of my PhD project was to investigate links between hepcidin regulation and cellular metabolism. My work describes for the first time that citrate metabolism controls hepcidin expression. A previously reported genome-wide RNAi screen generated a first comprehensive atlas of hepatocytic hepcidin regulators. To study metabolic signals that control hepcidin expression, I selected putative hepcidin regulators from the screening data, noting that several are specifically involved in citrate metabolism. I show that the siRNA-mediated knockdown of the enzymes that catalyze citrateconsuming reactions ACO1 (cytosolic aconitase), ACO2 (mitochondrial aconitase) and ACLY (ATP citrate lyase), as well as the inhibition of their enzymatic activities by small molecules, increases hepcidin mRNA expression in primary murine hepatocytes (PMH). Treatment of PMH with citrate furthermore results in the increase of citrate in cells and increased hepcidin expression. I further demonstrate that citrate acts intracellularly to regulate hepcidin via the BMP/SMAD signaling pathway. Injection of citrate into the tail vein of mice supports my findings that citrate increase in the liver augments hepcidin expression as well as the activity of BMP/SMAD signaling also in vivo. All together, my results uncover the cross-talk between iron homeostasis and intermediary metabolism, and may help to explain why iron levels are altered in several metabolic disorders.